These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 27655911

  • 1. Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN, Osorio M, Filipova S, Marsh C, Stibitz S, Kopecko DJ.
    Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27655911
    [Abstract] [Full Text] [Related]

  • 2. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 3. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ.
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [Abstract] [Full Text] [Related]

  • 4. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
    Xu DQ, Cisar JO, Osorio M, Wai TT, Kopecko DJ.
    Vaccine; 2007 Aug 14; 25(33):6167-75. PubMed ID: 17629369
    [Abstract] [Full Text] [Related]

  • 5. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y, Chakravarty S, Li M, Wai TT, Hoffman SL, Sim BK.
    J Infect Dis; 2017 Jan 15; 215(2):259-268. PubMed ID: 27803169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.
    Dharmasena MN, Feuille CM, Starke CE, Bhagwat AA, Stibitz S, Kopecko DJ.
    PLoS One; 2016 Jan 15; 11(9):e0163511. PubMed ID: 27673328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
    Xu DQ, Cisar JO, Ambulos N, Burr DH, Kopecko DJ.
    Infect Immun; 2002 Aug 15; 70(8):4414-23. PubMed ID: 12117952
    [Abstract] [Full Text] [Related]

  • 11. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.
    Clin Vaccine Immunol; 2007 Oct 15; 14(10):1285-95. PubMed ID: 17687110
    [Abstract] [Full Text] [Related]

  • 12. Introduction of Shigella flexneri 2a type and group antigen genes into oral typhoid vaccine strain Salmonella typhi Ty21a.
    Baron LS, Kopecko DJ, Formal SB, Seid R, Guerry P, Powell C.
    Infect Immun; 1987 Nov 15; 55(11):2797-801. PubMed ID: 3312013
    [Abstract] [Full Text] [Related]

  • 13. Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.
    Klee SR, Tzschaschel BD, Singh M, Fält I, Lindberg AA, Timmis KN, Guzmán CA.
    Microb Pathog; 1997 Jun 15; 22(6):363-76. PubMed ID: 9188091
    [Abstract] [Full Text] [Related]

  • 14. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
    Viret JF, Cryz SJ, Lang AB, Favre D.
    Mol Microbiol; 1993 Jan 15; 7(2):239-52. PubMed ID: 7680409
    [Abstract] [Full Text] [Related]

  • 15. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH, Kantele JM, Herzog C, Kantele A.
    Vaccine; 2014 Jan 23; 32(5):544-51. PubMed ID: 24342246
    [Abstract] [Full Text] [Related]

  • 16. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
    Fält IC, Schweda EK, Klee S, Singh M, Floderus E, Timmis KN, Lindberg AA.
    J Bacteriol; 1995 Sep 23; 177(18):5310-5. PubMed ID: 7545156
    [Abstract] [Full Text] [Related]

  • 17. Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.
    Xiong K, Zhu C, Chen Z, Zheng C, Tan Y, Rao X, Cong Y.
    Front Cell Infect Microbiol; 2017 Sep 23; 7():135. PubMed ID: 28484685
    [Abstract] [Full Text] [Related]

  • 18. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
    Black RE, Levine MM, Clements ML, Losonsky G, Herrington D, Berman S, Formal SB.
    J Infect Dis; 1987 Jun 23; 155(6):1260-5. PubMed ID: 2437220
    [Abstract] [Full Text] [Related]

  • 19. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
    Herrington DA, Van de Verg L, Formal SB, Hale TL, Tall BD, Cryz SJ, Tramont EC, Levine MM.
    Vaccine; 1990 Aug 23; 8(4):353-7. PubMed ID: 2204243
    [Abstract] [Full Text] [Related]

  • 20. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
    Hotz C, Fensterle J, Goebel W, Meyer SR, Kirchgraber G, Heisig M, Fürer A, Dietrich G, Rapp UR, Gentschev I.
    Int J Med Microbiol; 2009 Feb 23; 299(2):109-19. PubMed ID: 18706861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.